Kailera Therapeutics KLRA
NASDAQ KLRA
$13.27 +0.06 (+0.45%)
At close: Nov 13, 2026 · 4:00 PM EST

Kailera Therapeutics (KLRA) Enterprise Value (2026)

Updated

Kailera Therapeutics (KLRA) posted Enterprise Value of $579.54 million for Q3 2026, down 56.6% from the prior quarter.

Analysis

Kailera Therapeutics (KLRA) Enterprise Value (2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Enterprise Value at Kailera Therapeutics was -$1.4 billion.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Kailera Therapeutics 1.72 Bn -1.16 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 579.54 Mn
Jun 30, 2026 1.34 Bn
API Access

Kailera Therapeutics Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=KLRA&period=max&api_key=YOUR_API_KEY